Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00283530 · ClinicalTrials.gov registry record
Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer
A clinical trial, sponsored by Kentuckiana Cancer Institute.
- Terminated
- Registry status
- 1,000
- Enrollment target
NCT00283530: Clinical Trial study, sponsored by Kentuckiana Cancer Institute.
NCT00283530 is a clinical trial that was terminated before completion, run by Kentuckiana Cancer Institute. The registered enrollment target is 1,000 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00283530 was terminated before completion, sponsored by Kentuckiana Cancer Institute.
- TERMINATED
- Registry status
- 1,000 participants
- Enrollment target
Study Summary
The purpose of this study is to identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.
Interventions
- PROCEDURE Tumor biopsy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,000 participants |
| Start Date | 2003-05 |
| Est. Completion | 2009-07 |
Why NCT00283530 stopped before completion
NCT00283530 is an observational study that tracks outcomes without assigning an intervention. Its 1,000 participants enrollment target places it among the larger protocols in the corpus.
The record links to 0 conditions, and to 1 intervention - of which Tumor biopsy is the first listed.
NCT00283530 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00283530 about?
NCT00283530 is a clinical study titled "Tumor Phenotypes and Correlation to Clinical Outcomes in Cancer". The purpose of this study is to identify the genetic makeup of cancers, the cancer response, and the correlation of the cancer response to standardized regimens of cancer treatment.
What is the current status of trial NCT00283530?
This trial is currently terminated. The enrollment target is 1,000 participants. The study started on 2003-05. Estimated completion is 2009-07.
What interventions are being tested in trial NCT00283530?
The interventions under investigation include: Tumor biopsy (PROCEDURE).
Who is sponsoring clinical trial NCT00283530?
This trial is sponsored by Kentuckiana Cancer Institute, which has 5 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00018044 · 1,000 participants
Study of Mycobacterial Infections
- NCT01036581 · 1,000 participants · NA
Advanced Functional and Structural MRI Techniques for Neuropharmacological Imaging
- NCT01192048 · 1,000 participants
Genetics of Congenital Heart Disease
- NCT01553214 · 1,000 participants · Phase 4
Improving White Blood Cell Collection From Healthy Donors
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia